The Hong Kong Science and Technology Parks Corporation announced today (20th) that it has signed a co-incubation program agreement with Merck, a leading global science and technology company focusing on research and development, to promote biotechnology innovation and digital healthcare development in Hong Kong for a period of three years.
Successfully matched start-ups will receive financing and financial support from the Science Park. Merck will also help explore investment opportunities in the international market, hoping to promote Hong Kong to become the world's top biotechnology center.
▼Science and Technology Park signed a joint incubation plan agreement with Merck, a science and technology company▼
Huang Keqiang, CEO of Hong Kong Science and Technology Parks Corporation, said that both Science and Technology Parks Corporation and Merck are committed to using science to affect life and health. The number of biotech companies located in the Science Park has increased by 150% in the past five years. It is hoped that this cooperation will enable Hong Kong to achieve A vision for a world-class biotech hub.
Science and Technology Park Company provides 6 million yuan financing plan
Liu Siya, senior director of the Translational Research and Development Institute of the Hong Kong Science and Technology Park Corporation, said that Merck is the fifth multinational enterprise partner under the co-incubation cooperation of the Science and Technology Park. At least five eligible biomedical technology start-ups focusing on digital health solutions will participate. The Science and Technology Park Company will provide financing solutions of up to 6 million yuan. The selected start-ups can also use the laboratory equipment in the park to transform research results. for commercial products.
Yu Wenhui, Managing Director of Merck Hong Kong, said that there is no shortage of biotech talents in Hong Kong. Merck will help the participating start-ups to break out of Hong Kong to expand their international network. If there is a suitable digital medical solution, Merck will not rule out making it. invest.
Start-ups push Metaverse Theater performers 3D reality and audience interaction Zero Waste Invest Hong Kong says more than 300 start-ups came to Hong Kong last year